CreditReports.dk
HomeScreen companies

BASE life science A/S Financials, key figures and credit report

CVR number: 30906942 Established 2007 Industry: 70 Activities of head offices and management consultancy
Company contact details
Lyngbyvej 2, 2100 København Ø contact@baselifescience.com tel: 88202120 www.baselifescience.com
Gross profit 93 921.0 kDKK FY 2024 +0.6% vs 2023
EBIT -39 260.8 kDKK FY 2024 +38.7% vs 2023
Net debt -29 454.0 kDKK FY 2024 -132.5% vs 2023
Quick ratio 1.6 FY 2024 +0.6 vs 2023

Income statement (kDKK)

2020
2021
2022
2023
2024
Fiscal period length1212121212
Net sales
Gross profit93 829.70117 471.3484 927.8093 372.4493 920.95
Employee benefit expenses-76 910.38-92 369.85- 147 348.71- 153 668.59- 130 296.13
Total depreciation- 138.38- 903.57-2 849.63-3 717.12-2 885.61
EBIT16 780.9524 197.92-65 270.54-64 013.27-39 260.78
Other financial income109.67243.3560.43160.644 839.35
Other financial expenses- 280.54- 447.27- 528.25-3 556.89-4 297.21
Net income from associates (fin.)6 435.5934 479.08-20 514.63-12 096.73
Pre-tax profit16 610.0830 429.59-31 259.28-87 924.15-50 815.38
Income taxes-2 848.17-6 234.7935.003.04811.50
Net earnings13 761.9124 194.81-31 224.29-87 921.12-50 003.88

Assets (kDKK)

2020
2021
2022
2023
2024
Development expenditure4 123.264 824.693 859.752 894.811 929.88
Intangible rights83.0765.2747.47
Intangible assets total4 123.264 824.693 942.822 960.081 977.34
Machinery and equipment460.293 081.773 907.502 769.524 392.62
Tangible assets total460.293 081.773 907.502 769.524 392.62
Holdings in group member companies886.2410 596.2244 800.4225 919.1514 469.53
Investments total1 355.1611 521.4145 852.2327 185.0416 024.75
Long term receivables total
Inventories total
Current trade debtors30 769.9966 635.9743 722.6753 601.0255 463.04
Current amounts owed by group member comp.1 520.868 203.8622 060.9320 491.1526 225.40
Current owed by particip. interest comp.172.12
Prepayments and accrued income392.254 062.732 464.544 118.872 348.37
Current other receivables8 012.337 545.7428 400.4032 273.3823 424.26
Current deferred tax assets921.39767.00
Short term receivables total41 616.8186 448.2996 820.65111 251.42107 461.07
Cash and bank deposits6 597.92114.274 123.4011 804.3567 401.43
Cash and cash equivalents6 597.92114.274 123.4011 804.3567 401.43
Balance sheet total (assets)54 153.44105 990.43154 646.60155 970.41197 257.21

Equity and liabilities (kDKK)

2020
2021
2022
2023
2024
Share capital600.00600.00597.40597.40600.40
Share premium account164 123.00
Shares repurchased2 109.00
Other reserves4 123.2613 235.5646 612.5425 345.2511 052.21
Retained earnings5 575.1812 184.905 510.58-4 234.13-77 649.92
Profit of the financial year13 761.9124 194.81-31 224.29-87 921.12-50 003.88
Shareholders equity total26 169.3550 215.2721 496.23-66 212.6048 121.81
Provisions1 250.001 265.271 017.99802.66731.91
Non-current loans from credit institutions1 923.29
Non-current owed to group member97 379.5436 819.54
Non-current liabilities total1 923.2997 379.5436 819.54
Current loans from credit institutions110.683 063.09347.65589.27503.57
Advances received256.35947.682 389.61
Current trade creditors3 772.8022 052.0362 424.4857 535.1864 681.41
Current owed to participating513.06513.06
Current owed to group member4 037.214 358.09624.32
Short-term deferred tax liabilities3 451.767 938.332 982.57
Other non-interest bearing current liabilities16 470.7819 995.7259 950.8761 518.2645 774.65
Accruals and deferred income235.36
Current liabilities total24 810.8054 509.90132 132.39124 000.81111 583.94
Balance sheet total (liabilities)54 153.44105 990.43154 646.60155 970.41197 257.21
Page generated